Kynam Capital Management, LP Vera Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

$1.18 Billion
Q3 2025

A detailed history of Kynam Capital Management, LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 4,027,800 shares of VERA stock, worth $114 Million. This represents 9.86% of its overall portfolio holdings.

Number of Shares

4,027,800

Previous 3,426,887 17.54%

Holding current value

$114 Million

Previous $80.7 Million 44.48%

% of portfolio

9.86%

Previous 9.64%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$19.25 - $28.96 $11.6 Million - $17.4 Million	600,913 Added 17.54%	4,027,800 $117 Million
Q2 2025 Aug 14, 2025	BUY	$18.86 - $32.0 $19.4 Million - $32.9 Million	1,026,887 Added 42.79%	3,426,887 $80.7 Million
Q1 2025 May 15, 2025	BUY	$24.02 - $43.22 $22.6 Million - $40.7 Million	942,090 Added 64.62%	2,400,000 $57.6 Million
Q4 2024 Feb 14, 2025	SELL	$38.64 - $49.75 $4.58 Million - $5.9 Million	-118,639 Reduced 7.53%	1,457,910 $61.7 Million
Q3 2024 Nov 14, 2024	BUY	$34.09 - $46.71 $1.12 Million - $1.54 Million	32,880 Added 2.13%	1,576,549 $69.7 Million
Q2 2024 Aug 14, 2024	BUY	$33.72 - $48.82 $569,261 - $824,179	16,882 Added 1.11%	1,543,669 $55.8 Million
Q1 2024 May 15, 2024	SELL	$14.91 - $49.14 $31.7 Million - $104 Million	-2,123,552 Reduced 58.17%	1,526,787 $65.8 Million
Q4 2023 Feb 14, 2024	BUY	$9.29 - $16.0 $6.45 Million - $11.1 Million	694,286 Added 23.49%	3,650,339 $56.1 Million
Q3 2023 Nov 14, 2023	SELL	$13.71 - $19.64 $602,513 - $863,119	-43,947 Reduced 1.46%	2,956,053 $40.5 Million
Q2 2023 Aug 14, 2023	SELL	$6.11 - $17.83 $2.28 Million - $6.64 Million	-372,428 Reduced 11.04%	3,000,000 $48.2 Million
Q1 2023 May 15, 2023	BUY	$5.41 - $18.3 $10.6 Million - $35.9 Million	1,963,330 Added 139.33%	3,372,428 $26.2 Million
Q4 2022 Feb 14, 2023	SELL	$15.74 - $22.19 $2 Million - $2.82 Million	-127,083 Reduced 8.27%	1,409,098 $27.3 Million
Q3 2022 Nov 14, 2022	BUY	$13.27 - $22.31 $178,733 - $300,493	13,469 Added 0.88%	1,536,181 $32.7 Million
Q2 2022 Aug 15, 2022	BUY	$12.82 - $23.4 $13.1 Million - $23.9 Million	1,020,384 Added 203.13%	1,522,712 $20.7 Million
Q1 2022 May 13, 2022	BUY	$17.8 - $28.06 $4.43 Million - $6.98 Million	248,879 Added 98.2%	502,328 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$15.01 - $35.8 $3.8 Million - $9.07 Million	253,449 New	253,449 $6.77 Million

Others Institutions Holding VERA

# of Institutions

194

Shares Held

65.9M

Call Options Held

128K

Put Options Held

172K

View Full List

About Vera Therapeutics, Inc.

Ticker VERA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,042,300
Market Cap $766M
Description
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...

More about VERA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Kynam Capital Management, LP with notifications on news.

Account

Kynam Capital Management, LP Vera Therapeutics, Inc. Transaction History